Compare TECX & EGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | TECX | EGY |
|---|---|---|
| Founded | 2019 | 1985 |
| Country | United States | United States |
| Employees | 60 | N/A |
| Industry | | Oil & Gas Production |
| Sector | | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 545.3M | 652.7M |
| IPO Year | N/A | 1996 |
| Metric | TECX | EGY |
|---|---|---|
| Price | $30.82 | $6.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $75.25 | $7.30 |
| AVG Volume (30 Days) | 167.5K | ★ 1.8M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.31% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $359,272,000.00 |
| Revenue This Year | N/A | $8.78 |
| Revenue Next Year | N/A | $29.81 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.39 | $3.14 |
| 52 Week High | $35.99 | $6.72 |
| Indicator | TECX | EGY |
|---|---|---|
| Relative Strength Index (RSI) | 56.04 | 52.45 |
| Support Level | $17.71 | $3.51 |
| Resistance Level | $32.27 | $6.72 |
| Average True Range (ATR) | 1.52 | 0.25 |
| MACD | -0.24 | -0.09 |
| Stochastic Oscillator | 68.80 | 35.90 |
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
VAALCO Energy Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil, natural gas, and natural gas liquids (NGLs). It has a diversified, African-focused portfolio of production, development, and exploration assets located in Gabon, Egypt, Cote d'Ivoire, Equatorial Guinea, and Nigeria, which are also considered its reportable operating segments. Maximum revenue is generated from the Gabon segment, which holds working interest in and operates the Etame Marin block, located offshore Gabon. The company derives all of its revenue from crude oil, natural gas, and natural gas liquids sales.